Arif Asif

TL;DR: The 2019 update to the KDOQI Clinical Practice Guideline for Vascular Access is a comprehensive document intended to assist multidisciplinary practitioners care for chronic kidney disease patients and their vascular access.

TL;DR: This review will initially explore novel concepts about the pathology and pathogenesis of AV fistula failure to suggest potential therapeutic interventions for this important, yet unmet clinical need.

TL;DR: Because the majority of the cases developed pancreatic dysfunction within five cycles of therapy, in addition to the evaluation of other systems, pancreatic function should be closely monitored to minimize adverse impact on patients.

TL;DR: It is suggested hydroxychloroquine, either alone or in combination with azithromycin, was not associated with a survival benefit among hospitalized COVID-19 patients, and tocilizumab demonstrated a trend association towards reduced mortality among ICU patients.

TL;DR: Patients with chronic kidney disease (CKD) have a high prevalence of atherosclerotic cardiovascular disease, likely reflecting the presence of traditional risk factors and an increase in inflammatory mediators and vascular calcification secondary to hyperparathyroidism of renal origin that are unique to patients with CKD.